ClinicalTrials.Veeva

Menu

Efficacy and Safety of TORS for SCCA

K

Katherine L Fedder

Status

Active, not recruiting

Conditions

Supraglottic Squamous Cell Carcinoma
Oropharyngeal Squamous Cell Carcinoma

Treatments

Procedure: Transoral robotic surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT01819480
16376 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to learn more about the outcomes of treatment of throat and voice box cancers using transoral robotic surgery (TORS). TORS is a relatively new option involving the use of the da Vinci surgical robot to remove these cancers through the mouth.

Enrollment

110 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult male or female
  • Diagnosis of either oropharyngeal or supraglottic squamous cell carcinoma

Exclusion criteria

  • Metastatic disease

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

110 participants in 1 patient group

Transoral robotic surgery
Experimental group
Description:
Transoral robotic surgery
Treatment:
Procedure: Transoral robotic surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems